Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: IMA

Yiling Pharmaceutical: Lianhua Qingwen Approved in Nigeria


SHIJIAZHUANG, China, May 12, 2022 /PRNewswire/ -- Yiling Pharmaceutical disclosed Wednesday that it had received the medicine approval document for Lianhua Qingwen Capsules from the National Agency for Food and Drug Administration and Control (NAFDAC), Nigeria. The Product Category is Herbal and Nutraceuticals.

Lianhua Qingwen is one of Yiling's leading products. As a drug included in China's national essential medicines list and the catalog of medicines covered by China's national medical insurance system, Lianhua Qingwen has been selected for the Diagnosis and Treatment Protocols for COVID-19 Patients (4th-9th Editions) issued by China's National Health Commission, and widely used in the designated hospitals for Covid-19 patients.

As of now, Lianhua Qingwen has been granted market access in nearly 30 countries and regions. It has been approved COVID-19 indications in Kuwait; in July 2021, it has been adopted as a treatment in the COVID-19 patients' self-care protocol at home by the Cambodian Ministry of Health.

As the largest economic entity (GDP of USD 432.3 Billion in 2020) and most populous country (206 million people) in Africa, Nigeria is the headquarters of the Economic Community of West African States (ECOWAS) and becomes the 8th African country that has approved Lianhua Qingwen.

SOURCE Yiling Pharmaceutical


These press releases may also interest you

at 10:04
Finalists announced for CJF Jackman Excellence Award
The Canadian Journalism Foundation (CJF) is proud to announce its shortlists for the CJF Jackman Awards for Excellence in Journalism, honouring news organizations that embody exemplary journalism and have a profound positive impact on the communities...

at 10:01
Camping Equipment Market Expected to Reach $$51.8 billion Globally, by 2032 at 8.6% CAGR--Allied Market Research
...

at 09:56
Frasers Group & SmartRecruiters Partnership Slashes Retail Hiring to 10-Day Window
SmartRecruiters, an all-in-one hiring platform, has helped redefine recruitment in its partnership with Frasers Group, a leading British conglomerate of some of the world's most iconic sporting, luxury, and retail brands. The partnership has marked a...

at 09:52
University of Toronto scientists appointed as GSK chairs will advance drug delivery research and vaccine education tools for healthcare professionals
The University of Toronto's Leslie Dan Faculty of Pharmacy has announced the appointments of two leading scientists as endowed GSK research chairs. These appointments represent the collaborative efforts between the two organizations to advance the...

at 09:40
Clinical Trial by Harvard Pilgrim Health Care Institute, HCA Healthcare, UCI Health and CDC Identifies Strategy to Rapidly Detect and Respond to Hospital Outbreaks Using Algorithm-Driven Technology
An automated tool that improves outbreak detection for hundreds of pathogens successfully served as an early warning system to find and respond to potential hospital outbreaks, as reported today in NEJM Evidence. A Trial of Automated Outbreak...

at 09:20
Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical Conditions
Hyperfine, Inc. , the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system?the Swoop® system?today announced the acceptance of seventeen...

More news about Covid-19 virus...


News published on and distributed by: